This study is in progress, not accepting new patients
Safety, Tolerability, and Efficacy of Cilofexor in Non-Cirrhotic Adults With Primary Sclerosing Cholangitis
Summary
- Eligibility
- for people ages 18-75 (full criteria)
- Location
- at La Jolla, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Gilead Sciences
- ID
- NCT03890120
- Phase
- Phase 3 Primary Sclerosing Cholangitis Research Study
- Study Type
- Interventional
- Participants
- About 419 people participating
- Last Updated